Peptide Protocol

App Store

What to actually log in a peptide-tracking app

Peptide tracking sits on a continuum from "nothing" to "spreadsheet of 30 daily metrics." Most users start at the extremes and settle in the middle. The middle — seven categories logged consistently — produces enough information for dose decisions, side-effect management, and long-term review without the burden of obsessive logging.

The seven categories

1. Dose and time

The single most important data point. For weekly drugs: dose, day of week, time of day. For daily drugs: dose, date, time. Time precision matters less than consistency — same time each cycle is good.

Why: knowing your exact dose and the cumulative number of injections at each step is the foundation. A patient who can't answer "what dose are you on, and when was the last injection?" can't safely make any decision about the protocol.

2. Injection site

Zone, not exact spot. For weekly users on the 8-zone abdomen rotation, log "upper-right outer" or "Zone 1." For users rotating across body regions, log the region first.

Why: lipohypertrophy prevention requires rotation discipline. Log the site, get a rotation history, and the choice of next site becomes automatic.

3. GI symptoms per day

A simple 1–10 scale for nausea per day. Optionally include vomiting (binary), diarrhea (frequency), constipation (binary), reflux (1–10). Log daily, or at minimum on the symptomatic days.

Why: the 4-week nausea curve only becomes visible in logged data. Without a log, "this week is worse than last" becomes a vague memory; with a log, it's a chart.

4. Weight (weekly)

Once per week, same day, same time, fasted morning. Weekly is the right cadence for GLP-1 weight loss — daily is noise, monthly is too sparse.

Why: the 4-week moving average smooths out daily fluctuations and reveals the real trend. Both plateaus and accelerations become clear.

5. Glucose (if diabetic or on insulin/SU)

For diabetic patients or those on insulin/sulfonylureas, daily fingerstick or CGM data is essential. For non-diabetics on GLP-1 for weight loss, glucose tracking is optional.

Why: GLP-1 + insulin or SU combinations carry real hypoglycemia risk. Without glucose data, dose adjustment is guesswork.

6. Appetite rating per meal

A 1–5 score for fullness or appetite, ideally at each meal. Optional but very useful in the first 8 weeks of GLP-1 use.

Why: catches the very-early signs of dose tolerance (appetite returning) and helps distinguish "today's headache is not appetite-related" from "the drug isn't working anymore."

7. Physical activity

At minimum: resistance training sessions per week (count) and walking minutes per day. More granular activity tracking is fine but not necessary.

Why: muscle preservation on GLP-1 depends on training + protein. Without a log, "I worked out a lot this week" is unverifiable. With a log, the chart shows actual consistency.

What's nice-to-have

• Protein intake (daily total). Useful for hitting the 1.2–1.5 g/kg target. Some users log daily; others spot-check weekly.
• Sleep duration. Affects glucose and appetite; mildly affects training recovery. Log if you suspect sleep is a factor in symptoms.
• Body measurements. Waist circumference monthly is more useful than weight alone for visualizing fat loss.
• Mood / energy. If you're tracking mental health alongside metabolic, a 1–10 daily score works.

What's overkill

• Body fat percentage from home scales. Bioimpedance scales are too noisy for daily tracking. Use them weekly at most, and treat as rough.
• Detailed food macros. Unless you're actively manipulating macros, daily macro logging is a chore that produces little decision-relevant data.
• HRV, recovery scores from wearables. Interesting but rarely change a peptide-protocol decision.
• Mood × time-of-day correlations. Too noisy to extract signal.

How long to log

Most users log densely for the first 8–12 weeks of a new protocol, then taper to weekly weight + monthly check-ins once steady state is reached. The dense early logging captures the titration period when decisions are most active.

What to actually do with the logged data

1. Weekly review (10 minutes): look at weight trend, symptom trend, dose decisions.
2. Monthly review (30 minutes): body-comp trajectory, training consistency, side-effect patterns.
3. Per-titration decision: review the previous 4-week curve before advancing to the next dose.
4. Provider visit: bring the log. Lets the prescriber see actual data instead of recall.

Privacy considerations

Health data is sensitive. A tracking app should:

• Keep data local when possible (no required cloud upload).
• Not require account creation if you don't want sync.
• Not share data with third parties or advertisers.
• Let you export your data in a portable format.

If your tracking app is asking for excessive permissions or trying to monetize the data, that's a signal to find a different one.

FAQ

Do I need a special app or is a paper log fine?

Paper works for dose + time + site. For trend visualization (weight, symptoms over 4 weeks), an app makes the patterns visible in ways paper doesn't. Both can be valid; the worst tool is the one you don't use.

Should I share my log with my prescriber?

Yes, especially at titration decisions. A logged record beats verbal recall every time and lets the prescriber give precise guidance.

What if I miss a day?

Don't backfill from memory. Mark it as missing and continue. A few gaps in 12 weeks doesn't ruin the picture. Fabricated data is worse than missing data.

Is logging itself a behavioral nudge?

Yes. Self-monitoring of weight and food intake has been shown to support weight loss across multiple studies, independent of any drug. Logging makes you more aware of the patterns, which often shifts behavior in helpful directions.

Related reading

Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.